Last updated on March 2019

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of ixekizumab in pediatric participants with moderate-to-severe plaque psoriasis.

Clinical Study Identifier: NCT03073200

Contact Investigators or Research Sites near you

Start Over

Jerry Bagel

Psoriasis Treatment Center of Central New Jersey
East Windsor, NJ United States
0.32miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.